CDH1 and colorectal carcinoma: To further validate that E-cadherin levels have an impact on the response of CRC cells to Cetuximab, DLD1 exhibiting strong E-cadherin protein expression were subjected to control- and E-cadherin-specific siRNA treatment followed by analysis of antibody-dependent cellular cytotoxicity.